Meyka Pro banner
Heartseed, Inc.

Heartseed, Inc. Fundamental Analysis (JPX: 219A.T)

219A.TJPX
HealthcareBiotechnology
¥2322.00
¥78.00(3.48%)
Japanese Market opens in 10h 48m

Heartseed, Inc. Fundamental Analysis (JPX: 219A.T)

Heartseed, Inc. (JPX: 219A.T) shows weak financial fundamentals with a PE ratio of -81.34, profit margin of -42.48%, and ROE of -9.36%. The company generates $1.6B in annual revenue with weak year-over-year growth of 2.46%.

Key Strengths

Cash Position11.60%
Current Ratio30.13

Areas of Concern

ROE-9.36%
Operating Margin-81.57%
PEG Ratio4.37
We analyze 219A.T's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 23.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
23.8/100

We analyze 219A.T's fundamental strength across five key dimensions:

Efficiency Score

Weak

219A.T struggles to generate sufficient returns from assets.

ROA > 10%
-9.50%

Valuation Score

Moderate

219A.T shows balanced valuation metrics.

PE < 25
-81.34
PEG Ratio < 2
4.37

Growth Score

Weak

219A.T faces weak or negative growth trends.

Revenue Growth > 5%
2.46%
EPS Growth > 10%
1.20%

Financial Health Score

Excellent

219A.T maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
30.13

Profitability Score

Weak

219A.T struggles to sustain strong margins.

ROE > 15%
-936.22%
Net Margin ≥ 15%
-42.48%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is 219A.T Expensive or Cheap?

P/E Ratio

219A.T trades at -81.34 times earnings. This suggests potential undervaluation.

-81.34

PEG Ratio

When adjusting for growth, 219A.T's PEG of 4.37 indicates potential overvaluation.

4.37

Price to Book

The market values Heartseed, Inc. at 8.20 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

8.20

EV/EBITDA

Enterprise value stands at -83.14 times EBITDA. This is generally considered low.

-83.14

How Well Does 219A.T Make Money?

Net Profit Margin

For every $100 in sales, Heartseed, Inc. keeps $-42.48 as profit after all expenses.

-42.48%

Operating Margin

Core operations generate -81.57 in profit for every $100 in revenue, before interest and taxes.

-81.57%

ROE

Management delivers $-9.36 in profit for every $100 of shareholder equity.

-9.36%

ROA

Heartseed, Inc. generates $-9.50 in profit for every $100 in assets, demonstrating efficient asset deployment.

-9.50%

Following the Money - Real Cash Generation

Operating Cash Flow

Heartseed, Inc. generates strong operating cash flow of $1.08B, reflecting robust business health.

$1.08B

Free Cash Flow

Heartseed, Inc. generates strong free cash flow of $1.05B, providing ample flexibility for dividends, buybacks, or growth.

$1.05B

FCF Per Share

Each share generates $45.94 in free cash annually.

$45.94

FCF Yield

219A.T converts 1.93% of its market value into free cash.

1.93%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-81.34

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

4.37

vs 25 benchmark

P/B Ratio

Price to book value ratio

8.20

vs 25 benchmark

P/S Ratio

Price to sales ratio

34.65

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

30.13

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.09

vs 25 benchmark

ROA

Return on assets percentage

-0.09

vs 25 benchmark

ROCE

Return on capital employed

-0.19

vs 25 benchmark

How 219A.T Stacks Against Its Sector Peers

Metric219A.T ValueSector AveragePerformance
P/E Ratio-81.3432.14 Better (Cheaper)
ROE-9.36%550.00% Weak
Net Margin-42.48%30133.00% Weak
Debt/Equity0.000.56 Strong (Low Leverage)
Current Ratio30.135.70 Strong Liquidity
ROA-9.50%3.00% Weak

219A.T outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Heartseed, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

490.59%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

111.26%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

154.76%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ